Skip to main content

Advertisement

SpringerLink
Log in

Lateral Neck Lymph Node Characteristics Prognostic of Outcome in Patients with Clinically Evident N1b Papillary Thyroid Cancer

  • Endocrine Tumors
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Purpose

To identify lateral lymph node (LN) characteristics predictive of outcome in papillary thyroid cancer patients with clinically evident nodal disease.

Methods

A total of 438 patients with lateral neck metastases from papillary thyroid cancer were identified from an institutional database of 3,664 differentiated thyroid cancers. The number of positive LNs, size of the largest LN, number of positive LNs to total number of LNs removed (LN burden), and presence of extranodal spread (ENS) were recorded. Cutoffs for continuous variables were determined by receiver operating characteristic curves. LN variables predictive of recurrence free survival and disease-specific survival (DSS) were identified by the Kaplan–Meier method and the Cox proportional hazard model.

Results

The median age was 41 years (range 5–86 years). The median follow-up was 65 months (range 1–332 months). Fifty-nine patients developed disease recurrence; these were local in five, regional in 40, and distant in 30 patients. Fifteen patients died of disease. Receiver operating characteristic cutoffs were >10 positive LNs and a LN burden >17 %. No lateral LN characteristics were predictive of DSS. In patients <45 years old, univariate predictors of recurrence were >10 positive nodes (p = 0.049) and LN burden >17 % (p < 0.001). In patients ≥45 years old, >10 positive nodes, LN burden >17 %, and presence of ENS were predictive of recurrence (p = 0.019, p = 0.019, and p = 0.029, respectively).

Conclusions

LN burden >17 % (1 positive LN in 6 LNs removed) in the lateral neck is predictive for recurrence in patients of all ages, whereas ENS is also prognostic for recurrence in older patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Shaha AR, Loree TR, Shah JP. Intermediate-risk group for differentiated carcinoma of thyroid. Surgery. 1994;116:1036–40.

    CAS  PubMed  Google Scholar 

  2. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery. 1993;114:1050–7.

    CAS  PubMed  Google Scholar 

  3. Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery. 1988;104:947–53.

    CAS  PubMed  Google Scholar 

  4. Sobin LH, Gospodarowicz MK, Wittekind CW. TNM classification of malignant tumours. 7th ed. New York: Wiley-Blackwell; 2009.

    Google Scholar 

  5. Lang BHH, Wong KP, Wan KY, Lo CY. Significance of metastatic lymph node ratio on stimulated thyroglobulin levels in papillary thyroid carcinoma after prophylactic unilateral central neck dissection. Ann Surg Oncol. 2012;19:1257–63.

    Article  PubMed Central  PubMed  Google Scholar 

  6. Jeon M, Yoon J, Han J, et al. The prognostic value of the metastatic lymph node ratio and maximal metastatic tumor size in pathological N1a papillary thyroid carcinoma. Eur J Endocrinol. 2013;168:219–25.

    Article  CAS  PubMed  Google Scholar 

  7. Leboulleux S, Rubino C, Baudin E, et al. Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab. 2005;90:5723–9.

    Article  CAS  PubMed  Google Scholar 

  8. Lee J, Song Y, Soh E. Prognostic significance of the number of metastatic lymph nodes to stratify the risk of recurrence. World J Surg. 2013;4:4.

    Google Scholar 

  9. Sugitani I, Kasai N, Fujimoto Y, Yanagisawa A. A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery. 2004;135:139–48.

    Article  PubMed  Google Scholar 

  10. Ito Y, Jikuzono T, Higashiyama T, et al. Clinical significance of lymph node metastasis of thyroid papillary carcinoma located in one lobe. World J Surg. 2006;30:1821–8.

    Article  PubMed  Google Scholar 

  11. Nixon I, Wang L, Palmer F, et al. The impact of nodal status on outcome in older patients with papillary thyroid cancer. Surgery. 2014;156:137–46.

    Article  PubMed  Google Scholar 

  12. Ito Y, Fukushima M, Tomoda C, et al. Prognosis of patients with papillary thyroid carcinoma having clinically apparent metastasis to the lateral compartment. Endocr J. 2009;56:759–66.

    Article  PubMed  Google Scholar 

  13. Moreno MA, Agarwal G, de Luna R, et al. Preoperative lateral neck ultrasonography as a long-term outcome predictor in papillary thyroid cancer. Arch Otolaryngol Head Neck Surg. 2011;137:157–62.

    Article  PubMed  Google Scholar 

  14. Marchet A, Mocellin S, Ambrosi A, et al. The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients. Ann Surg. 2007;245:543–52.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Dekker J, Peeters K, Putter H, Vahrmeijer A, van de Velde C. Metastatic lymph node ratio in stage III rectal cancer; prognostic significance in addition to the 7th edition of the TNM classification. Eur J Surg Oncol. 2010;36:1180–6.

    Article  CAS  PubMed  Google Scholar 

  16. Berger A, Watson J, Ross E, Hoffman J. The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am Surg. 2004;70:235–40.

    PubMed  Google Scholar 

  17. Woodward W, Vinh-Hung V, Ueno N, et al. Prognostic value of nodal ratios in node-positive breast cancer. J Clin Oncol. 2006;24:2910–6.

    Article  PubMed  Google Scholar 

  18. Gil Z, Carlson D, Boyle J, et al. Lymph node density is a significant predictor of outcome in patients with oral cancer. Cancer. 2009;115:5700–10.

    Article  PubMed  Google Scholar 

  19. Mizrachi A, Hadar T, Rabinovics N, et al. Prognostic significance of nodal ratio in cutaneous squamous cell carcinoma of the head and neck. Eur Arch Otorhinolaryngol. 2013;270:647–53.

    Article  PubMed  Google Scholar 

  20. Beal S, Chen S, Schneider P, Martinez S. An evaluation of lymph node yield and lymph node ratio in well-differentiated thyroid carcinoma. Am Surg. 2010;76:28–32.

    PubMed  Google Scholar 

  21. Wang L, Palmer F, Nixon I, et al. Central lymph node characteristics predictive of outcome in patients with differentiated thyroid cancer. Thyroid. 2014;30:30.

    CAS  Google Scholar 

  22. Lee Y, Lim Y, Lee J, et al. Nodal status of central lymph nodes as a negative prognostic factor for papillary thyroid carcinoma. J Surg Oncol. 2013;107:777–82.

    Article  PubMed  Google Scholar 

  23. Carter R, Bliss J, Soo K, O’Brien C. Radical neck dissections for squamous carcinomas: pathological findings and their clinical implications with particular reference to transcapsular spread. Int J Radiat Oncol Biol Phys. 1987;13:825–32.

    Article  CAS  PubMed  Google Scholar 

  24. Johnson J, Myers E, Bedetti C, Barnes E, Schramm VJ, Thearle P. Cervical lymph node metastases. Incidence and implications of extracapsular carcinoma. Arch Otolaryngol. 1985;111:534–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Disclosure

The authors declare no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Surgery Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA

    Laura Y. Wang MBBS, MS, Frank L. Palmer BA, Iain J. Nixon MBChB, Jatin P. Shah MD, Snehal G. Patel MD, Ashok R. Shaha MD & Ian Ganly MD, PhD

  2. Department of Medicine Endocrine Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA

    R. Michael Tuttle MD

Authors
  1. Laura Y. Wang MBBS, MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Frank L. Palmer BA
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Iain J. Nixon MBChB
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. Michael Tuttle MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jatin P. Shah MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Snehal G. Patel MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ashok R. Shaha MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ian Ganly MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ian Ganly MD, PhD.

Electronic Supplementary Material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 474 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, L.Y., Palmer, F.L., Nixon, I.J. et al. Lateral Neck Lymph Node Characteristics Prognostic of Outcome in Patients with Clinically Evident N1b Papillary Thyroid Cancer. Ann Surg Oncol 22, 3530–3536 (2015). https://doi.org/10.1245/s10434-015-4398-2

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-015-4398-2

Keywords

Search

Navigation